President Biden proposed extending Medicare price negotiations to more prescription drugs. The White House put out word Tuesday morning that as part of its campaign to keep the Medicare program for seniors solvent, its newly formed drug price negotiations should be extended to even more drugs and take effect more quickly. (Endpoints News)

WeightWatchers agreed to buy the parent company of Sequence, a subscription telehealth platform that offers weight management programs and medication prescriptions, including for Ozempic and Wegovy. The deal value was $132 million in cash and stock, with sellers including venture firm DCM. (Axios)

Rapport Therapeutics, a neuroscience startup, launched with $100 million in funding from Third Rock as well as Johnson & Johnson. Rapport aims to tackle new challenges in neuroscience. (Boston Business Journal)

Ionis Pharmaceuticals said the Food and Drug Administration accepted for review its New Drug Application for nerve disease drug candidate eplontersen. The drug is used for the treatment of hereditary transthyretin-mediated amyloid polyneuropathy. (MarketWatch)

Walgreens urged a court to toss a proposed class-action lawsuit alleging it duped parents into buying kids’ cough medicine that’s more expensive than an identical adults’ product. Joycette Goodwin sued the retail chain in January, saying the products’ different labels make consumers think the company’s Children’s 12-Hour Cough Relief Cough DM is more suitable for children. (Bloomberg)